My laboratory is interested in T cell responses in settings of transplantation, autoimmunity and cancer, with an emphasis on mouse models and emerging extensions onto clinical translation. A main focus of the laboratory is on T cell tolerance in transplantation and how infections and inflammatory events can affect induction or maintenance of tolerance. We have found that transplantation tolerance can exist at different levels of robustness based on the number of mechanisms of T cell tolerance that are engaged, and that infections or inflammation can erode such tolerance. The impact of bacterial infections on transplant outcomes has led us to discover that the microbiota also influences immune responses to transplanted organs and can be manipulated to prolong graft survival. Our clinical studies have focused on the immunology of transplant recipients and of patients infected with the bacteria that influence transplant outcomes and, collaboratively, we have explored the involvement of the microbiota in the responsiveness of melanoma patients to immunotherapy.
Host-microbiota interactions in the esophagus during homeostasis and allergic inflammation
M. Brusilovsky, R. Bao, M. Rochman, A.M. Kemter, C.R. Nagler, & M.E. Rothenberg. (2022) Gastroenterology 162(2): 521-534.e8.
Distinct molecular phenotypes involving several human diseases are induced by IFN-λ3 and IFN-λ4 in monocyte-derived macrophages
M. De, A. Bhushan, W.S. Grubbe, S. Roy, J.L. Mendoza, & S. Chinnaswamy. (2022) Genes Immun (in press).
VEGF-A, PDGF-BB and HB-EGF engineered for promiscuous super affinity to the extracellular matrix improve wound healing in a model of type 1 diabetes
M.J.V. White, P.S. Briquez, D.A.V. White, & J.A. Hubbell. (2021) NPJ Regen Med 6(1): 76.
Antigen multimers: Specific, sensitive, precise, and multifunctional high-avidity CAR-staining reagents
Y. Hu, G. Cao, X. Chen, X. Huang, N. Asby, N. Ankenbruck, A. Rahman, A. Thusu, Y. He, P.A. Riedell, M.R. Bishop, H. Schreiber, J.P. Kline, & J. Huang. (2021) Matter 4(12): 3917-3940.
A Multifunctional Neutralizing Antibody-Conjugated Nanoparticle Inhibits and Inactivates SARS-CoV-2
X. Cai, M. Chen, A. Prominski, Y. Lin, N. Ankenbruck, J. Rosenberg, M. Nguyen, J. Shi, A. Tomatsidou, G. Randall, D. Missiakas, J. Fung, E.B. Chang, P. Penaloza-MacMaster, B. Tian, & J. Huang. (2021) Adv Sci e2103240.
Generation of potent cellular and humoral immunity against SARS-CoV-2 antigens via conjugation to a polymeric glyco-adjuvant
L.T. Gray, M.M. Raczy, P.S. Briquez, T.M. Marchell, A.T. Alpar, R.P. Wallace, L.R. Volpatti, M.S. Sasso, S. Cao, M. Nguyen, A. Mansurov, E. Budina, E.A. Watkins, A. Solanki, N. Mitrousis, J.W. Reda, S.S. Yu, A.C. Tremain, R. Wang, V. Nicolaescu, K. Furlong, S. Dvorkin, B. Manicassamy, G. Randall, D.S. Wilson, M. Kwissa, M.A. Swartz, & J.A. Hubbell. (2021) Biomaterials 278: 121159.
High-throughput RNA sequencing of paraformaldehyde-fixed single cells
H.V. Phan, M. van Gent, N. Drayman, A. Basu, M.U. Gack, & S. Tay. (2021) Nat Comm 12(1): 5636.
Lymph Node-Targeted Synthetically Glycosylated Antigen Leads to Antigen-Specific Immunological Tolerance
C.D. Maulloo, S. Cao, E.A. Watkins, M.M. Raczy, A.S. Solanki, M. Nguyen, J.W. Reda, H.N. Shim, D.S. Wilson, M.A. Swartz, & J.A. Hubbell. (2021) Front Immunol 12: 714842.
Exosomes: Small vesicles with big roles in cancer, vaccine development, and therapeutics
A. Thakur, D.C. Parra, P. Motallebnejad, M. Brocchi, & H.J. Chen. (2021) Bioact Mater 10: 281-294.
Improving the Adjuvanticity of Small Molecule Immune Potentiators Using Covalently Linked NF-κB Modulators
F.W. Kimani, S. Manna, B. Moser, J. Shen, N. Nihesh, & A.P. Esser-Kahn. (2021) ACS Med Chem Lett 12(9): 1441-1448.